Evidence map›Paper›PMID 27054505›Full record

ReviewCurrent opinion in cardiology2016

Bleeding and thrombosis in chronic ventricular assist device therapy: focus on platelets.

Antigone Koliopoulou, Stephen H McKellar, Matthew Rondina, Craig H Selzman

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Recognition of Strokes in the ICU: A Narrative Review.Journal of cardiovascular development and disease · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Medical and Surgical Management of Left Ventricular Assist Device-Associated Intracranial Hemorrhage.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2021
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Antigone KoliopoulouaDivision of Cardiothoracic SurgerybDepartment of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.
Stephen H McKellar
Matthew Rondina
Craig H Selzman
University of Utah · US

Funding

Translational Research Skills Development CoreU54HL112311 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S, ZIMMERMAN, GUY A. · 2012 to 2016
$12.9M
The Effects of ART on Platelets and HIV-Associated ThrombosisR01HL126547 · NHLBI · UNIVERSITY OF UTAH · PI PLANELLES, VICENTE, RONDINA, MATTHEW THOMAS · 2014 to 2017
$3.0M
Mechanisms of Myocardial RecoveryR01HL089592 · NHLBI · UNIVERSITY OF UTAH · PI SELZMAN, CRAIG HAROLD · 2009 to 2013
$1.8M
Platelet Immune Responses in Aging and InfluenzaR01AG048022 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2014 to 2018
$1.8M
NHLBI NIH HHS HL112311NHLBI NIH HHS HL126547NHLBI NIH HHS R01 HL089592NHLBI NIH HHS R01 HL126547NHLBI NIH HHS U54 HL112311NIA NIH HHS AG048022NIA NIH HHS R01 AG048022
6 · The paper itself

Abstract

purpose of reviewLeft ventricular assist devices (LVADs) have markedly improved the survival for patients with advanced heart failure but are plagued with significant morbidity, including pump thrombosis and bleeding. Better understanding of the platelet, and its role in the balance of bleeding and thrombosis, stands to impact the frequency and treatment of these significant complications. RECENT

findingsIn patients with LVADs, there is little consistency linking traditional biomarkers of platelet activation and clinical events. A number of innovative methods of assessing platelet functionality, including shedding of platelet receptors and formation of microparticle complexes as well as measuring mitochondrial membrane potentials, exist and appear to be clinically relevant. Acquired von Willebrand syndrome, while not explaining all bleeding events, is a central feature of mechanical support and offers a target for innovative therapies. SUMMARY: Although the platelet is only one component of impacting thrombosis and bleeding in patients supported with LVADs, it plays a central role in mediating these two opposing forces. Innovations in understanding platelet physiology as well as manipulating genomic and receptor interactions for an individual patient will be critical if we are to decrease these serious adverse events in the future.

Indexed as

Blood PlateletsCell-Derived MicroparticlesHeart-Assist DevicesHemorrhageHumansPlatelet ActivationThrombosisvon Willebrand Diseases

Identifiers

PMID27054505
PMCPMC4982370
OpenAlexW2329252178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.